| Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States DM Qato, GC Alexander, RM Conti, M Johnson, P Schumm, ST Lindau Jama 300 (24), 2867-2878, 2008 | 1350 | 2008 |
| Racial disparities in access to renal transplantation—clinically appropriate or due to underuse or overuse? AM Epstein, JZ Ayanian, JH Keogh, SJ Noonan, N Armistead, PD Cleary, ... New England Journal of Medicine 343 (21), 1537-1544, 2000 | 692 | 2000 |
| Pricing in the market for anticancer drugs DH Howard, PB Bach, ER Berndt, RM Conti Journal of Economic Perspectives 29 (1), 139-162, 2015 | 568 | 2015 |
| Impact of FDA black box advisory on antipsychotic medication use ER Dorsey, A Rabbani, SA Gallagher, RM Conti, GC Alexander Archives of internal medicine 170 (1), 96-103, 2010 | 260 | 2010 |
| Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review SB Dusetzina, AS Higashi, ER Dorsey, R Conti, HA Huskamp, S Zhu, ... Medical care 50 (6), 466-478, 2012 | 233 | 2012 |
| Overspending driven by oversized single dose vials of cancer drugs PB Bach, RM Conti, RJ Muller, GC Schnorr, LB Saltz Bmj 352, 2016 | 184 | 2016 |
| Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists RM Conti, AC Bernstein, VM Villaflor, RL Schilsky, MB Rosenthal, ... Journal of Clinical Oncology 31 (9), 1134-1139, 2013 | 184 | 2013 |
| Navigating financial toxicity in patients with cancer: a multidisciplinary management approach GL Smith, MP Banegas, C Acquati, S Chang, F Chino, RM Conti, ... CA: a cancer journal for clinicians 72 (5), 437-453, 2022 | 171 | 2022 |
| Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities R Conti, DL Veenstra, K Armstrong, LJ Lesko, SD Grosse Medical Decision Making 30 (3), 328-340, 2010 | 164 | 2010 |
| Mental health policy and psychotropic drugs RG Frank, RM Conti, HH Goldman The Milbank Quarterly 83 (2), 271-298, 2005 | 147 | 2005 |
| Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000–2010 CF Garfield, ER Dorsey, S Zhu, HA Huskamp, R Conti, SB Dusetzina, ... Academic pediatrics 12 (2), 110-116, 2012 | 127 | 2012 |
| Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States WV Padula, RA Larson, SB Dusetzina, JF Apperley, R Hehlmann, ... Journal of the National Cancer Institute 108 (7), djw003, 2016 | 114 | 2016 |
| 21st century pharmacovigilance: efforts, roles, and responsibilities PJ Pitts, H Le Louet, Y Moride, RM Conti The Lancet Oncology 17 (11), e486-e492, 2016 | 110 | 2016 |
| The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities RM Conti, PB Bach Health affairs 33 (10), 1786-1792, 2014 | 104 | 2014 |
| An analysis of whether higher health care spending in the United States versus Europe is ‘worth it’in the case of cancer T Philipson, M Eber, DN Lakdawalla, M Corral, R Conti, DP Goldman Health Affairs 31 (4), 667-675, 2012 | 95 | 2012 |
| Cost consequences of the 340B drug discount program RM Conti, PB Bach Jama 309 (19), 1995-1996, 2013 | 83 | 2013 |
| Association of opioid prescribing patterns with prescription opioid overdose in adolescents and young adults KP Chua, CM Brummett, RM Conti, A Bohnert JAMA pediatrics 174 (2), 141-148, 2020 | 82 | 2020 |
| Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998–2009 J Pillarella, A Higashi, GC Alexander, R Conti Psychiatric services 63 (1), 83-86, 2012 | 76 | 2012 |
| Association of prescription drug price rebates in Medicare Part D with patient out-of-pocket and federal spending SB Dusetzina, RM Conti, LY Nancy, PB Bach JAMA internal medicine 177 (8), 1185-1188, 2017 | 73 | 2017 |
| Racial and ethnic disparities in cardiovascular medication use among older adults in the United States DM Qato, ST Lindau, RM Conti, LP Schumm, GC Alexander Pharmacoepidemiology and drug safety 19 (8), 834-842, 2010 | 67 | 2010 |